Medication info
Telcatan Plus Tablet 40/12.5 mg

Telcatan Plus Tablet 40/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Hanmi Pharm Co., Ltd.
Appearance
An oval-shaped tablet consisting of two layers, white and pink, with possible pink speckles on the white layer.
Packaging
30 tablets (10 tablets/PTP*3)/box
Approval status
Active

MFDS item code 201000860 · Notified 2010.01.26 · Insurance code 659900420

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as individual products or with the combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This drug should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this drug per day. This drug should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dosage adjustment is necessary.
Child dose
Children The safety and efficacy of this drug have not been established in children under 18 years of age.

Ingredients

Manufacturer
Hanmi Pharm Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension. It helps effectively manage blood pressure in patients whose blood pressure cannot be adequately controlled with telmisartan alone. This contributes to reducing the risk of complications related to hypertension and improving health.

How to take

Adult dose

Adults Take once daily with a beverage, with or without food, in patients whose blood pressure is not adequately controlled with telmisartan alone. Before switching to this fixed-dose combination, it is recommended that the doses of each component be individually adjusted. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as individual products or with the combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dosage adjustment is necessary in patients with mild to moderate renal impairment. Do not administer this drug to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This drug should be administered with caution to patients with mild to moderate hepatic impairment. Do not administer more than 40/12.5mg of this drug per day. This drug should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired hepatic function. Elderly patients No dosage adjustment is necessary.

Child dose

Children The safety and efficacy of this drug have not been established in children under 18 years of age.

Precautions

This medication can pose serious risks to the fetus, especially during the second and third trimesters of pregnancy; therefore, if pregnancy is confirmed, use should be discontinued immediately. This medication should not be taken by individuals who have an allergy to its components or certain liver or kidney diseases. Elderly patients or those with elevated potassium levels or impaired liver function should take it with caution, and careful use is necessary in those with heart or vascular diseases. The hydrochlorothiazide component may increase the risk of skin cancer, so sun exposure should be avoided, and skin condition should be monitored regularly. During the use of this medication, side effects such as dizziness, low blood pressure, and electrolyte imbalance may occur, so if symptoms are severe, immediate consultation with healthcare professionals is necessary. It may interact with other antihypertensive medications, diuretics, lithium, and certain antiarrhythmics, so it is essential to inform the doctor about any other medications being taken. Pregnant or breastfeeding women should not take this medication, and if pregnancy is planned, switching to another safe alternative medication is recommended. In case of overdose, symptoms such as low blood pressure, electrolyte abnormalities, and dehydration may occur, so it is crucial to visit a hospital immediately for appropriate measures. This medication is not recommended for children under 18, as its safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 126 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pulmonary inflammation
  • pulmonary edema
  • diarrhea
  • dry mouth
  • abdominal distension
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver dysfunction
  • liver disorder
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased serum uric acid
  • increased serum creatinine
  • increased serum creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • eczema
  • drug rash
  • toxic skin eruption
  • bone pain
  • renal dysfunction
  • weakness
  • increased serum creatinine
  • increased serum uric acid
  • increased serum creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • aplastic anemia
  • jaundice
  • cholestasis
  • photosensitivity reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • acute renal failure
  • diabetes
  • renal dysfunction
  • weakness
  • fever
  • nausea
  • gastrointestinal bleeding
  • esophagitis
  • headache
  • tremors
  • facial flushing
  • malaise
  • fatigue
  • proteinuria
  • itching
  • myalgia
  • a feeling of heaviness
  • lip and hand tremors
  • sensory hypersensitivity
  • periodontal disease
  • chapped lips
  • vision deterioration
  • hypotension
  • tachycardia
  • bradycardia
  • acute respiratory distress syndrome
  • pancreatitis
  • angioedema
  • vasculitis
  • pulmonary edema
  • acute renal failure
  • acute myopia
  • angle-closure glaucoma
  • yellow vision
  • choroidal exudate
  • acute respiratory distress syndrome
  • ARDS
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air or moisture from entering, and it is important to maintain a storage temperature between 1°C and 30°C. Storing it this way helps maintain the effectiveness of the medication.

Appearance and packaging

Appearance

An oval-shaped tablet consisting of two layers, white and pink, with possible pink speckles on the white layer.

Package unit

30 tablets (10 tablets/PTP*3)/box

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.